£ million unless otherwise indicated | Notes | 2024 | 2023 | |
R evenue | 3 | |||
Duty and similar items | ( | ( | ||
Other cost of sales | ( | ( | ||
Cost of sales | ( | ( | ||
G ross profit | ||||
Distribution, advertising and selling costs | ( | ( | ||
Administrative and other expenses | ( | ( | ||
O perating profit | 4 | |||
Investment income | 5 | |||
Finance costs | 5 | ( | ( | |
| Net finance costs | ( | ( | ||
Share of profit of investments accounted for using the equity method | 15 | |||
P rofit before tax | ||||
Tax | 8 | ( | ( | |
P rofit for the year | ||||
| Attributable to: | ||||
| Owners of the parent | ||||
Non-controlling interests | ||||
E arnings per ordinary share (pence) | ||||
| • | Basic | 10 | ||
| • | Diluted | 10 |
£ million | Notes | 2024 | 2023 |
P rofit for the year | |||
O ther comprehensive income | |||
Exchange movements | ( | ( | |
Hyperinflation adjustment in the year | 1 | ||
| Current tax on hedge of net investments and quasi-equity loans | ( | ( | |
Items that may be reclassified to profit and loss | ( | ( | |
Net actuarial losses on retirement benefits | 24 | ( | ( |
Deferred tax relating to net actuarial losses on retirement benefits | |||
Items that will not be reclassified to profit and loss | ( | ( | |
O ther comprehensive expense for the year, ne t of tax | ( | ( | |
T otal comprehensive income for the year | |||
| Attributable to: | |||
| Owners of the parent | |||
Non-controlling interests | |||
T otal comprehensive income for the year |
£ million | Notes | 2024 | 2023 |
N on - current assets | |||
Intangible assets | 12 | ||
Property, plant and equipment | 13 | ||
Right of use assets | 14 | ||
Investments accounted for using the equity method | 15 | ||
Retirement benefit assets | 24 | ||
Trade and other receivables | 17 | ||
Derivative financial instruments | 21/22 | ||
Deferred tax assets | 23 | ||
C urrent assets | |||
Inventories | 16 | ||
Trade and other receivables | 17 | ||
Current tax assets | 8 | ||
Cash and cash equivalents | 18 | ||
Derivative financial instruments | 21/22 | ||
T otal assets | |||
C urrent liabilities | |||
Borrowings | 20 | ( | ( |
Derivative financial instruments | 21/22 | ( | ( |
Lease liabilities | 14 | ( | ( |
Trade and other payables | 19 | ( | ( |
Current tax liabilities | 8 | ( | ( |
Provisions | 25 | ( | ( |
( | ( | ||
N on - current liabilities | |||
Borrowings | 20 | ( | ( |
Derivative financial instruments | 21/22 | ( | ( |
Lease liabilities | 14 | ( | ( |
Trade and other payables | 19 | ( | ( |
Deferred tax liabilities | 23 | ( | ( |
Retirement benefit liabilities | 24 | ( | ( |
Provisions | 25 | ( | ( |
( | ( | ||
T otal liabilities | ( | ( | |
N et assets | |||
E quity | |||
Share capital | 26 | ||
Share premium and capital redemption | 26 | ||
| Retained earnings | ( | ( | |
Exchange translation reserve | ( | ||
E quity attributable to owners of the parent | |||
Non-controlling interests | |||
T otal equity |
| Equity | |||||||
| Share | attributable | ||||||
| premium | Exchange | to owners | Non- | ||||
| Share | and capital | Retained | translation | of the | controlling | Total | |
| £ million | capital | redemption | earnings | reserve | parent | interests | equity |
A t 1 O ctober 2023 | ( | ||||||
Profit for the year | |||||||
Exchange movements on retranslation of net assets | ( | ( | ( | ( | |||
Exchange movements on net investment hedges | |||||||
Exchange movements on quasi-equity loans | |||||||
Hyperinflation adjustment in the year | |||||||
| Current tax on hedge of net investments and quasi-equity | |||||||
| loans | ( | ( | ( | ||||
Net actuarial losses on retirement benefits | ( | ( | ( | ||||
| Deferred tax relating to net actuarial losses on retirement | |||||||
| benefits | |||||||
Other comprehensive expense | ( | ( | ( | ( | ( | ||
T otal comprehensive income/(expense) | ( | ||||||
T ransactions with owners | |||||||
| Costs of employees' services compensated by share | |||||||
| schemes | |||||||
Current tax on share-based payments | |||||||
Repurchase of shares | ( | ( | ( | ( | |||
Changes in non-controlling interests | ( | ( | ( | ( | |||
Deferred tax on share-based payments | |||||||
Remeasurement of put/call option | |||||||
Dividends paid | ( | ( | ( | ( | |||
A t 30 September 2024 | ( | ( | |||||
A t 1 October 2022 | ( | ||||||
Profit for the year | |||||||
Exchange movements on retranslation of net assets | ( | ( | ( | ( | |||
Exchange movements on net investment hedges | |||||||
Exchange movements on quasi-equity loans | |||||||
Hyperinflation adjustment in the year | |||||||
| Current tax on hedge of net investments and quasi-equity | |||||||
loans | ( | ( | ( | ||||
Net actuarial gains on retirement benefits | ( | ( | ( | ||||
| Deferred tax relating to net actuarial gains on retirement | |||||||
| benefits | |||||||
Other comprehensive expense | ( | ( | ( | ( | ( | ||
T otal c omprehensive income/(expense) | ( | ||||||
T ransactions with owners | |||||||
| Costs of employees' services compensated by share | |||||||
schemes | |||||||
Repurchase of shares | ( | ( | ( | ( | |||
Changes in non-controlling interests | ( | ||||||
Deferred tax on share-based payments | |||||||
Registration of put/call option | ( | ( | ( | ||||
Dividends paid | ( | ( | ( | ( | |||
A t 30 September 2023 | ( |
£ million | 2024 | 2023 |
C ash flows from operating activities | ||
Operating profit | ||
Dividends received from investments accounted for using the equity method | ||
Depreciation, amortisation and impairment | ||
Profit on disposal of non-current assets | ( | ( |
Loss on disposal of subsidiaries | ||
Post-employment benefits | ( | ( |
Share-based payments | ||
Other non-cash items | ( | |
Movement in provisions | ( | |
Operating cash flows before movement in working capital | ||
Decrease/(increase) in inventories | ( | |
(Increase)/decrease in trade and other receivables | ( | |
Increase in trade and other payables | ||
Movement in working capital | ( | |
Tax paid | ( | ( |
N et cash generated from operating activities | ||
C ash flows from investing ac t ivities | ||
Interest received | ||
Proceeds from the sale of non-current assets | ||
Purchase of non-current assets | ( | ( |
Purchase of brands and operations | ( | ( |
N et cash used in investing activities | ( | ( |
C ash flows from financing ac t ivities | ||
Acquisition of non-controlling interests | ( | |
Interest paid | ( | ( |
Lease liabilities paid | ( | ( |
Increase in borrowings | ||
Repayment of borrowings | ( | ( |
Cash flows relating to derivative financial instruments | ( | ( |
Repurchase of shares | ( | ( |
Dividends paid to non-controlling interests | ( | ( |
Dividends paid to owners of the parent | ( | ( |
N et cash used in financing activities | ( | ( |
N e t d e c r e a s e i n c a s h a n d c a s h e q u i v a l e n t s | ( | ( |
C ash and cash equ i valents at start of year | ||
Effect of foreign exchange rates on cash and cash equivalents | ( | ( |
C ash and cash equ i valents at end of year |
2024 | 2023 | |||
Closing rate | Average rate | Closing rate | Average rate | |
Euro | 1.1985 | 1.1694 | 1.1545 | 1.1487 |
US dollar | 1.3384 | 1.2681 | 1.2214 | 1.2264 |
2024 | 2023 | |||||
| Tobacco & | Tobacco & | |||||
£ million unless otherwise indicated | Tobacco | NGP | NGP | Tobacco | NGP | NGP |
Revenue | 21,708 | 376 | 22,084 | 22,114 | 299 | 22,413 |
Net revenue | 7,828 | 329 | 8,157 | 7,747 | 265 | 8,012 |
Operating profit/(loss) | 3,321 | (83) | 3,238 | 3,262 | (156) | 3,106 |
Adjusted operating profit | 3,587 | 3,583 | ||||
Adjusted operating margin % | 44.0 | 44.7 |
£ million unless otherwise indicated | 2024 | 2023 |
Revenue | 11,104 | 10,819 |
Distribution gross profit | 1,503 | 1,466 |
Operating profit | 322 | 298 |
Adjusted operating profit | 330 | 306 |
Adjusted operating margin % | 22.0 | 20.9 |
2024 | 2023 | |||
| Total | External | Total | External | |
| £ million | revenue | revenue | revenue | revenue |
| Tobacco & NGP | ||||
Europe | 12,037 | 11,260 | 11,749 | 10,992 |
Americas | 3,657 | 3,657 | 3,700 | 3,700 |
AAACE | 6,390 | 6,390 | 6,964 | 6,964 |
Total Tobacco & NGP | 22,084 | 21,307 | 22,413 | 21,656 |
Distribution | 11,104 | 11,104 | 10,819 | 10,819 |
Eliminations | (777) | – | (757) | – |
Total Group | 32,411 | 32,411 | 32,475 | 32,475 |
| 2024 | 2023 | |||||
| £ million | Tobacco | NGP | Total | Tobacco | NGP | Total |
Europe | 3,106 | 260 | 3,366 | 3,020 | 220 | 3,240 |
Americas | 2,793 | 43 | 2,836 | 2,778 | 34 | 2,812 |
AAACE | 1,929 | 26 | 1,955 | 1,949 | 11 | 1,960 |
Total Tobacco & NGP | 7,828 | 329 | 8,157 | 7,747 | 265 | 8,012 |
£ million | 2024 | 2023 |
| Tobacco & NGP | ||
Europe | 1,541 | 1,482 |
Americas | 1,235 | 1,257 |
AAACE | 811 | 844 |
Total Tobacco & NGP | 3,587 | 3,583 |
Distribution | 330 | 306 |
Eliminations | (6) | (2) |
Adjusted operating profit | 3,911 | 3,887 |
Russia, Ukraine and associated markets - Tobacco & NGP | – | (4) |
Amortisation and impairment of acquired intangibles - Tobacco & NGP | (345) | (339) |
Amortisation of acquired intangibles - Distribution | (8) | (8) |
Fair value adjustment and impairment of other financial assets - Tobacco & NGP | – | (36) |
Loss on disposal of subsidiaries - Tobacco & NGP | – | (1) |
Charges related to legal provisions - Tobacco & NGP | – | (85) |
Structural changes to defined benefit pension schemes - Tobacco & NGP | (4) | (12) |
Operating profit | 3,554 | 3,402 |
Net finance costs | (534) | (298) |
Share of profit of investments accounted for using the equity method | 9 | 7 |
Profit before tax | 3,029 | 3,111 |
| 2024 | ||||
| Additions to | Depreciation | Other | ||
| property, plant | and software | intangible asset | Inventory | |
| £ million | and equipment | amortisation | amortisation | impairments |
| Tobacco & NGP | ||||
Europe | 60 | 88 | 7 | 16 |
Americas | 30 | 27 | 1 | 4 |
AAACE | 51 | 40 | – | 11 |
Total Tobacco & NGP | 141 | 155 | 8 | 31 |
Distribution | 38 | 37 | – | – |
Total Group | 179 | 192 | 8 | 31 |
| 2023 | ||||
| Additions to | Depreciation | Other | ||
| property, plant | and software | intangible asset | Inventory | |
| £ million | and equipment | amortisation | amortisation | impairments |
| Tobacco & NGP | ||||
Europe | 69 | 79 | 10 | 30 |
Americas | 36 | 20 | 1 | 3 |
AAACE | 46 | 41 | – | 13 |
Total Tobacco & NGP | 151 | 140 | 11 | 46 |
Distribution | 40 | 41 | – | – |
Total Group | 191 | 181 | 11 | 46 |
2024 | 2023 | |||
| External | Non-current | External | Non-current | |
| £ million | revenue | assets | revenue | assets |
UK | 3,781 | 161 | 3,926 | 148 |
Germany | 4,501 | 3,156 | 4,142 | 3,245 |
France | 3,374 | 2,282 | 3,428 | 2,350 |
USA | 3,648 | 4,968 | 3,657 | 5,646 |
Other | 17,107 | 7,350 | 17,322 | 7,553 |
Total Group | 32,411 | 17,917 | 32,475 | 18,942 |
£ million | 2024 | 2023 |
Raw materials and consumables used | 950 | 773 |
Changes in inventories of finished goods - Tobacco & NGP | 2,516 | 2,630 |
Changes in inventories of finished goods - Distribution | 8,243 | 7,994 |
Depreciation and impairment of fixed assets | 153 | 153 |
Amortisation and impairment of intangible assets and investments accounted for using the equity method | 399 | 394 |
Expenses relating to short-term leases | 10 | 4 |
Expenses relating to low value asset leases | 2 | 1 |
Depreciation and impairment of right of use assets | 95 | 85 |
Net foreign exchange gains | (3) | (11) |
Write down of inventories | 28 | 40 |
Profit on disposal of non-current assets | 13 | 39 |
Write back of trade receivables | (3) | (5) |
£ million | 2024 | 2023 |
Parent Company and consolidated financial statements | 3.2 | 3.1 |
The Company's subsidiaries | 6.8 | 6.5 |
T otal audit fees | 10.0 | 9.6 |
Audit-related assurance services | 0.5 | 0.5 |
T o t a l a u d i t - r e l a t e d f e e s | 10.5 | 10.1 |
Other assurance services | 1.2 | 0.5 |
T otal non - audit fees | 1.2 | 0.5 |
T otal auditor's remuneration | 11.7 | 10.6 |
£ million | 2024 | 2023 |
I nvestment income | ||
Fair value gains on derivative financial instruments | 513 | 707 |
Net exchange gains on financing activities | 9 | 10 |
Interest income on net defined benefit assets | 22 | 43 |
Interest income on bank deposits | 16 | 12 |
T otal investment income | 560 | 772 |
F inance costs | ||
Fair value losses on derivative financial instruments | (632) | (568) |
Interest cost on net defined benefit liabilities | (33) | (30) |
Tax interest cost | (10) | (50) |
Interest cost on lease liabilities | (14) | (10) |
Interest cost on bank and other loans | (404) | (412) |
Effect of discounting on long-term provisions | (1) | – |
T otal finance costs | (1,094) | (1,070) |
N et finance costs | (534) | (298) |
2024 | 2023 | ||||
£ million | Costs | Cash spend | Costs | Cash spend | |
2021 | Strategic review programme | – | 25 | – | 61 |
Other | – | 18 | – | 37 | |
– | 43 | – | 98 |
£ million | 2024 | 2023 |
Wages and salaries | 923 | 882 |
Social security costs | 202 | 186 |
Other pension costs (note 24) | 29 | 41 |
1,154 | 1,109 | |
Share-based payments (note 27) | 32 | 31 |
1,186 | 1,140 |
£ million | 2024 | 2023 |
Base salary | 4.6 | 4.7 |
Benefits | 0.7 | 0.9 |
Pension salary supplement | 0.6 | 0.7 |
Bonus | 4.9 | 4.8 |
Termination payments | 0.2 | 2.1 |
LTIP annual vesting 1 | 7.2 | 7.8 |
18.2 | 21.0 |
£ million | 2024 | 2023 |
Short-term employee benefits | 17.7 | 17.0 |
Termination payments | 0.2 | 2.1 |
Share-based payments (in accordance with IAS 24) | 14.4 | 15.0 |
32.3 | 34.1 |
2024 | 2023 | |||
| At 30 | At 30 | |||
September | Average | September | Average | |
Tobacco & NGP | 18,900 | 18,400 | 18,800 | 19,100 |
Distribution | 6,700 | 6,500 | 6,400 | 6,400 |
25,600 | 24,900 | 25,200 | 25,500 |
2024 | 2023 | |||
| At 30 | At 30 | |||
| September | Average | September | Average | |
UK and European Union | 12,400 | 12,100 | 12,200 | 11,900 |
Americas | 4,900 | 4,700 | 4,700 | 5,100 |
Rest of the World | 8,300 | 8,100 | 8,300 | 8,500 |
25,600 | 24,900 | 25,200 | 25,500 |
2024 | 2023 | |
| UK current tax | ||
Current year credited to the consolidated income statement | (95) | (55) |
Current year charged to consolidated other comprehensive income | 197 | 115 |
Total current year UK current tax | 102 | 60 |
Adjustments in respect of prior years (credited)/charged to the consolidated income statement | (80) | 15 |
Total UK current tax | 22 | 75 |
| Overseas current tax | ||
Current year charged to the consolidated income statement | 704 | 620 |
Total current year overseas current tax | 704 | 620 |
Adjustments in respect of prior years charged to the consolidated income statement | 40 | 233 |
Total overseas current tax | 744 | 853 |
Total current tax charged to the consolidated statement of other comprehensive income | 766 | 928 |
£ million | 2024 | 2023 |
| UK current tax | ||
Current year | (95) | (55) |
Adjustments in respect of prior years | 80 | 15 |
| Overseas current tax | ||
Current year | 704 | 620 |
Adjustments in respect of prior years | 40 | 233 |
Total current tax | 569 | 813 |
| Deferred tax | ||
Relating to origination and reversal of temporary differences | (287) | (158) |
T otal tax charged to the c o nsolidated income statement | 282 | 655 |
£ million | 2024 | 2023 |
| Tax related to items recognised in consolidated other comprehensive income during the year: | ||
Current tax on hedge of net investment and quasi-equity loans | 197 | 115 |
Total current tax | 197 | 115 |
Deferred tax on actuarial gains and losses | (37) | (135) |
Deferred tax on hyperinflation adjustment | 2 | 1 |
Total deferred tax | (35) | (134) |
Total tax credited to consolidated other comprehensive income | 162 | (19) |
£ million | 2024 | 2023 |
| Tax related to items recognised in equity during the year: | ||
Current tax on share-based payments | (4) | – |
Deferred tax on share-based payments | (2) | (1) |
Total tax credited to equity | (6) | (1) |
£ million | 2024 | 2023 |
Profit before tax | 3,029 | 3,111 |
Tax at the UK corporation tax rate of 25.0% (2023: 22.0%) | 757 | 684 |
| Tax effects of: | ||
Differences in effective tax rates on overseas earnings | (56) | 24 |
Movement in provision for uncertain tax positions | 170 | 211 |
Remeasurement of deferred tax balances arising from changes in tax rates | 5 | – |
Recognition of deferred tax assets for tax credits | (293) | – |
Remeasurement of previously recognised deferred tax assets | (2) | (6) |
Increase in previously unrecognised deferred tax assets | – | 1 |
Deferred tax on unremitted earnings | 12 | 5 |
Share of profit of investments accounted for using the equity method | (2) | (2) |
Non-deductible expenses | 24 | 24 |
Non-taxable gains on net foreign exchange on financial instruments | (198) | (122) |
Recognition of deferred tax assets | – | (212) |
Provision for state aid tax recoverable | (101) | – |
Adjustments in respect of prior years | (34) | 48 |
Total tax charged to the consolidated income statement | 282 | 655 |
£ million | 2024 | 2023 |
At 1 October | (306) | 27 |
Charged to the consolidated income statement | (569) | (813) |
Charged to other comprehensive income | (197) | (115) |
Credited to equity | 4 | – |
Cash paid | 888 | 590 |
Exchange movements | 17 | 6 |
Balance sheet reclassification | – | (1) |
At 30 September | (163) | (306) |
£ million | 2024 | 2023 |
State aid tax recoverable | 101 | – |
Current tax assets | 148 | 112 |
Current tax liabilities | (412) | (418) |
(163) | (306) |
Pence per share | £ million | |||||
2024 | 2023 | 2022 | 2024 | 2023 | 2022 | |
C ash: | ||||||
D ecember | 51.82 | 49.31 | 48.47 | 461 | 464 | 458 |
M arch | 51.82 | 49.32 | 48.49 | 453 | 457 | 458 |
J une | 22.45 | 21.59 | 21.27 | 193 | 196 | 202 |
S eptember | 22.45 | 21.59 | 21.27 | 192 | 195 | 202 |
T otal | 148.54 | 141.81 | 139.50 | 1,299 | 1,312 | 1,320 |
£ million | 2024 | 2023 |
Earnings: basic and diluted - attributable to owners of the Parent Company | 2,613 | 2,328 |
| Millions of shares | ||
| Weighted average number of shares: | ||
Shares for basic earnings per share | 869.0 | 922.5 |
Potentially dilutive share options | 4.9 | 5.7 |
Shares for diluted earnings per share | 873.9 | 928.2 |
| Pence | ||
Basic earnings per share | 300.7 | 252.4 |
Diluted earnings per share | 299.0 | 250.8 |
| 2024 | |||||
| Intellectual | |||||
| property and | |||||
| product | Supply | ||||
| £ million | Goodwill | development | agreements | Software | Total |
At 1 October 2023 | 13,785 | 13,042 | 1,457 | 630 | 28,914 |
Additions | – | 115 | 2 | 143 | 260 |
Acquisitions | 2 | 1 | 2 | – | 5 |
Disposals | – | (1) | (2) | (4) | (7) |
Reclassifications | 29 | – | 1 | (30) | – |
Exchange movements | (632) | (814) | (53) | (17) | (1,516) |
At 30 September 2024 | 13,184 | 12,343 | 1,407 | 722 | 27,656 |
A mortisation and impairment | |||||
At 1 October 2023 | 1,556 | 8,650 | 1,389 | 375 | 11,970 |
Amortisation charge for the year | – | 354 | 7 | 38 | 399 |
Disposals | – | – | – | (3) | (3) |
Exchange movements | (56) | (525) | (50) | (17) | (648) |
Accumulated amortisation | – | 7,940 | 1,346 | 392 | 9,678 |
Accumulated impairment | 1,500 | 539 | – | 1 | 2,040 |
At 30 September 2024 | 1,500 | 8,479 | 1,346 | 393 | 11,718 |
N et book value | |||||
At 30 September 2024 | 11,684 | 3,864 | 61 | 329 | 15,938 |
| 2023 | |||||
| Intellectual | |||||
| property and | |||||
| product | Supply | ||||
£ million | Goodwill | development | agreements | Software | Total |
At 1 October 2022 | 14,228 | 13,871 | 1,433 | 522 | 30,054 |
Additions | – | 136 | 1 | 119 | 256 |
Acquisitions | 67 | 5 | 54 | 2 | 128 |
Disposals | – | (115) | – | (3) | (118) |
Reclassifications | – | (2) | – | 2 | – |
Exchange movements | (510) | (853) | (31) | (12) | (1,406) |
At 30 September 2023 | 13,785 | 13,042 | 1,457 | 630 | 28,914 |
A mortisation and impairment | |||||
At 1 October 2022 | 1,587 | 8,925 | 1,414 | 351 | 12,277 |
Amortisation charge for the year | – | 352 | 6 | 34 | 392 |
Disposals | – | (109) | – | (3) | (112) |
Reclassifications | – | (1) | – | 1 | – |
Exchange movements | (31) | (517) | (31) | (8) | (587) |
Accumulated amortisation | – | 8,111 | 1,389 | 374 | 9,874 |
Accumulated impairment | 1,556 | 539 | – | 1 | 2,096 |
At 30 September 2023 | 1,556 | 8,650 | 1,389 | 375 | 11,970 |
N et b ook value | |||||
At 30 September 2023 | 12,229 | 4,392 | 68 | 255 | 16,944 |
A ssets under construction included above: | |||||
At 30 September 2024 | 261 | ||||
At 30 September 2023 | 1 6 0 |
2024 | 2023 | |||
| Intangible | Intangible | |||
| assets with | assets with | |||
| indefinite | indefinite | |||
£ million | Goodwill | lives | Goodwill | lives |
Europe | 3,919 | 296 | 4,123 | 307 |
Americas | 3,945 | – | 4,147 | – |
AAACE | 2,076 | 156 | 2,181 | 162 |
Tobacco & NGP | 9,940 | 452 | 10,451 | 469 |
Distribution | 1,744 | – | 1,778 | – |
11,684 | 452 | 12,229 | 469 |
2024 | 2023 | |||||
| Pre-tax | Initial growth | Long-term | Pre-tax | Initial growth | Long-term | |
| % | discount rate | rate | growth rate | discount rate | rate | growth rate |
Europe | 9.9 | 4.1 | 0.2 | 10.4 | 4.5 | 1.0 |
Americas | 8.7 | 6.5 | 1.9 | 8.9 | 5.8 | 2.1 |
AAACE | 13.3 | 2.0 | 1.9 | 12.5 | 4.3 | 2.2 |
Distribution | 12.1 | 4.1 | 1.6 | 12.3 | 5.0 | 1.6 |
| 2024 | ||||
| Fixtures | ||||
| Plant and | and motor | |||
£ million | Property | equipment | vehicles | Total |
At 1 October 2023 | 756 | 2,065 | 484 | 3,305 |
Additions | 10 | 127 | 41 | 178 |
Acquisitions | – | 1 | – | 1 |
Disposals | (24) | (69) | (48) | (141) |
Hyperinflation adjustment (note 1) | 1 | 10 | 1 | 12 |
Reclassifications | 18 | (5) | (13) | – |
Exchange movements | (25) | (81) | (15) | (121) |
At 30 September 2024 | 736 | 2,048 | 450 | 3,234 |
D epreciation and impairment | ||||
At 1 October 2023 | 177 | 1,203 | 308 | 1,688 |
Depreciation charge for the year | 16 | 102 | 36 | 154 |
Impairment | (3) | 2 | – | (1) |
Disposals | (12) | (47) | (46) | (105) |
Reclassifications | – | 4 | (4) | – |
Exchange movements | (10) | (42) | (11) | (63) |
At 30 September 2024 | 168 | 1,222 | 283 | 1,673 |
N et book value | ||||
At 30 September 2024 | 568 | 826 | 167 | 1,561 |
| 2023 | ||||
| Fixtures | ||||
| Plant and | and motor | |||
£ million | Property | equipment | vehicles | Total |
At 1 October 2022 | 806 | 2,080 | 455 | 3,341 |
Additions | 3 | 130 | 58 | 191 |
Acquisitions | – | 5 | 9 | 14 |
Disposals | (22) | (74) | (24) | (120) |
Hyperinflation adjustment (note 1) | – | 5 | – | 5 |
Exchange movements | (31) | (81) | (14) | (126) |
At 30 September 2023 | 756 | 2,065 | 484 | 3,305 |
D epreciation and impairment | ||||
At 1 October 2022 | 181 | 1,200 | 301 | 1,682 |
Depreciation charge for the year | 17 | 98 | 32 | 147 |
Impairment | – | 6 | – | 6 |
Disposals | (11) | (60) | (15) | (86) |
Exchange movements | (10) | (41) | (10) | (61) |
At 30 September 2023 | 177 | 1,203 | 308 | 1,688 |
N et book value | ||||
At 30 September 2023 | 579 | 862 | 176 | 1,617 |
A ssets under construction included above: | ||||
At 30 September 2024 | 122 | |||
At 30 September 2023 | 107 |
| 2024 | ||||
| Fixtures | ||||
| Plant and | and motor | |||
£ million | Property | equipment | vehicles | Total |
N et book value | ||||
At 1 October 2023 | 256 | 2 | 68 | 326 |
Additions and modifications | 82 | 4 | 69 | 155 |
Terminations | (4) | (1) | (5) | (10) |
Depreciation and impairment | (57) | (3) | (35) | (95) |
Exchange movements | (10) | – | (4) | (14) |
At 30 September 2024 | 267 | 2 | 93 | 362 |
| Lease | |
| £ million | Liabilities |
At 1 October 2023 | 349 |
Cash flow | (107) |
Accretion of interest | 14 |
New leases, terminations and modifications | 144 |
Exchange movements | (14) |
At 30 September 2024 | 386 |
£ million | 2024 | 2023 |
Expenses relating to short-term leases | 10 | 4 |
Expenses relating to low value asset leases | 2 | 1 |
Depreciation and impairment expense of right of use assets | 95 | 85 |
Interest on lease liabilities | 14 | 10 |
| 2023 | ||||
| Fixtures | ||||
| Plant and | and motor | |||
| £ million | Property | equipment | vehicles | Total |
N et book v alue | ||||
At 1 October 2022 | 194 | 3 | 31 | 228 |
Additions and modifications | 74 | 3 | 35 | 112 |
Acquisitions | 50 | – | 34 | 84 |
Terminations | (3) | – | (2) | (5) |
Depreciation | (53) | (4) | (28) | (85) |
Exchange movements | (6) | – | (2) | (8) |
At 30 September 2023 | 256 | 2 | 68 | 326 |
| Lease | |
| £ million | Liabilities |
At 1 October 2022 | 248 |
Cash flow | (92) |
Accretion of interest | 10 |
New leases, terminations and modifications | 106 |
Acquisitions | 84 |
Exchange movements | (7) |
At 30 September 2023 | 349 |
| 2024 | |||
| Global | |||
| Horizon | |||
| £ million | Ventures | Others | Total |
Revenue | 25 | 40 | 65 |
Profit after tax | 17 | 3 | 20 |
Non-current assets | – | 8 | 8 |
Current assets | 60 | 62 | 122 |
Total assets | 60 | 70 | 130 |
Current liabilities | (11) | (56) | (67) |
Non-current liabilities | – | (13) | (13) |
Total liabilities | (11) | (69) | (80) |
Net assets | 49 | 1 | 50 |
| 2023 | |||
| Global | |||
| Horizon | |||
| £ million | Ventures | Others | Total |
Revenue | 19 | 28 | 47 |
Profit after tax | 13 | 4 | 17 |
Non-current assets | – | 7 | 7 |
Current assets | 56 | 49 | 105 |
Total assets | 56 | 56 | 112 |
Current liabilities | (7) | (41) | (48) |
Non-current liabilities | – | (14) | (14) |
Total liabilities | (7) | (55) | (62) |
Net assets | 49 | 1 | 50 |
| Transactions and balances with joint ventures | |||
£ million | 2024 | 2023 | |
Purchases from | 9 | 4 | |
Accounts payable to | (4) | (2) |
£ million | 2024 | 2023 |
At 1 October | 55 | 56 |
Share of profit for the year from joint ventures | 9 | 7 |
Share of profit for the year from associates | 1 | 2 |
Impairment of investment in associates | – | (2) |
Dividends | (9) | (7) |
Foreign exchange losses | – | (1) |
At 30 September | 56 | 55 |
£ million | 2024 | 2023 |
Raw materials | 960 | 1,159 |
Work in progress | 84 | 81 |
Finished inventories | 2,887 | 3,106 |
Other inventories | 149 | 176 |
4,080 | 4,522 |
2024 | 2023 | |||
£ million | Current | Non-current | Current | Non-current |
Trade receivables | 2,395 | 1 | 2,211 | 3 |
Less: loss allowance | (64) | (1) | (63) | (3) |
Net trade receivables | 2,331 | – | 2,148 | – |
Other receivables | 156 | 37 | 149 | 26 |
Prepayments | 158 | 81 | 193 | 37 |
2,645 | 118 | 2,490 | 63 |
2024 | 2023 | |||
£ million | Current | Non-current | Current | Non-current |
Within credit terms | 2,194 | – | 1,996 | – |
Past due by less than 3 months | 111 | – | 121 | – |
Past due by more than 3 months | 26 | – | 31 | – |
Amounts that are impaired | 64 | 1 | 63 | 3 |
2,395 | 1 | 2,211 | 3 |
£ million | 2024 | 2023 |
| At 1 October | 66 | 79 |
Net decrease in provision | (1) | (13) |
At 30 September | 65 | 66 |
£ million | 2024 | 2023 |
Cash at bank and in hand | 607 | 683 |
Short-term deposits and other liquid assets | 471 | 662 |
1,078 | 1,345 |
2024 | 2023 | |||
£ million | Current | Non-current | Current | Non-current |
Trade payables | 1,499 | – | 1,507 | – |
Duties payable | 5,156 | – | 5,297 | – |
Other taxes and social security contributions | 1,381 | – | 1,375 | – |
Other payables | 623 | – | 526 | – |
Accruals | 838 | 86 | 874 | 27 |
9,497 | 86 | 9,579 | 27 |
£ million | 2024 | 2023 |
| Current borrowings | ||
Bank loans and overdrafts | 34 | 49 |
| Capital market issuance: | ||
European commercial paper (ECP) | 21 | – |
£600m 8.125% notes due March 2024 | – | 627 |
US$ 1,000m 3.125% notes due July 2024 | – | 823 |
500m 1.375% notes due January 2025 | 421 | – |
US$ 950m 4.25% notes due July 2025 | 715 | – |
Total current borrowings | 1,191 | 1,499 |
| Non-current borrowings | ||
Bank loans | – | 2 |
| Capital market issuance: | ||
500m 1.375% notes due January 2025 | – | 437 |
US$ 1,500m 4.25% notes due July 2025 | – | 1,236 |
650m 3.375% notes due February 2026 | 553 | 574 |
US$ 750m 3.5% notes due July 2026 | 563 | 617 |
£500m 5.5% notes due September 2026 | 500 | 500 |
750m 2.125% notes due February 2027 | 634 | 657 |
US$ 1,000m 6.125% notes due July 2027 | 752 | 822 |
US$ 1,000m 3.875% notes due July 2029 | 751 | 822 |
US$ 1,250m 5.5% notes due February 2030 | 944 | – |
1,050m 5.25% notes due February 2031 | 898 | 838 |
£500m 4.875% notes due June 2032 | 505 | 505 |
1,000m 1.75% notes due March 2033 | 840 | 872 |
US$ 750m 5.875% notes due July 2034 | 566 | – |
Total non-current borrowings | 7,506 | 7,882 |
Total borrowings | 8,697 | 9,381 |
| Analysed as: | ||
Capital market issuance | 8,663 | 9,330 |
Bank loans and overdrafts | 34 | 51 |
2024 | 2023 | |||
| Balance | Balance | |||
| sheet | sheet | |||
| £ million | amount | Fair value | amount | Fair value |
GBP | 1,006 | 985 | 1,632 | 1,524 |
EUR | 3,367 | 3,245 | 3,378 | 2,996 |
USD | 4,290 | 4,303 | 4,320 | 4,097 |
Total capital market issuance | 8,663 | 8,533 | 9,330 | 8,617 |
£ million | 2024 | 2023 |
| Amounts maturing: | ||
In less than one year | 853 | 550 |
Between one and two years | 153 | 159 |
Between two and five years | 2,608 | 2,866 |
3,614 | 3,575 |
2024 | 2023 | |
| Increase/ | Increase/ | |
| (decrease) | (decrease) | |
| £ million | in income | in income |
| Income statement impact of non-functional currency foreign exchange exposures: | ||
10% appreciation of sterling against euro (2023: 10%) | 87 | 33 |
10% appreciation of sterling against US dollar (2023: 10%) | (17) | (9) |
10% depreciation of sterling against euro (2023: 10%) | (106) | (41) |
10% depreciation of sterling against US dollar (2023: 10%) | 20 | 11 |
2024 | 2023 | |
| Change in | Change in | |
| £ million | equity | equity |
| Equity impact of non-functional currency foreign exchange exposures: | ||
10% appreciation of sterling against euro (2023: 10%) | 928 | 1,035 |
10% appreciation of sterling against US dollar (2023: 10%) | 272 | 205 |
10% depreciation of sterling against euro (2023: 10%) | (1,134) | (1,265) |
10% depreciation of sterling against US dollar (2023: 10%) | (332) | (250) |
2024 | 2023 | |
| Change in | Change in | |
| £ million | income | income |
| Income statement impact of interest rate movements: | ||
+/- 1% increase in euro interest rates (2023: 1%) | 1 | 12 |
+/- 1% increase in US dollar interest rates (2023: 1%) | (2) | (9) |
2024 | 2023 | |
| Maximum | Maximum | |
| exposure to | exposure to | |
| credit risk | credit risk | |
| Counterparty exposure | £ million | £ million |
Highest | 253 | 311 |
2nd highest | 134 | 104 |
3rd highest | 50 | 84 |
4th highest | 27 | 83 |
5th highest | 10 | 80 |
| 2024 | ||||||
| Contractual | ||||||
| Balance sheet | cash flows | Between 1 and | Between 2 and | |||
| £ million | amount | total | <1 year | 2 years | 5 years | > 5 years |
| Non-derivative financial liabilities: | ||||||
Bank loans | 34 | 34 | 34 | – | – | – |
Capital market issuance | 8,663 | 10,218 | 1,497 | 1,911 | 2,752 | 4,058 |
Trade payables | 1,499 | 1,499 | 1,499 | – | – | – |
Lease liabilities | 386 | 435 | 96 | 82 | 144 | 113 |
Total non-derivative financial liabilities | 10,582 | 12,186 | 3,126 | 1,993 | 2,896 | 4,171 |
| 2023 | ||||||
| Contractual | ||||||
| Balance sheet | cash flows | Between 1 and | Between 2 and | |||
| £ million | amount | total | <1 year | 2 years | 5 years | > 5 years |
| Non-derivative financial liabilities: | ||||||
Bank loans | 51 | 51 | 49 | 2 | – | – |
Capital market issuance | 9,330 | 10,663 | 1,767 | 1,951 | 3,651 | 3,294 |
Trade payables | 1,507 | 1,507 | 1,507 | – | – | – |
Lease liabilities | 349 | 406 | 82 | 70 | 114 | 140 |
Total non-derivative financial liabilities | 11,237 | 12,627 | 3,405 | 2,023 | 3,765 | 3,434 |
£ million | 2024 | 2023 |
Adjusted net debt | 7,740 | 8,026 |
Equity attributable to the owners of the parent | 5,442 | 6,021 |
Total capital | 13,182 | 14,047 |
| 2024 | |||||
| Total | Maturity | ||||
| notional | Between 1 and | Between 2 and | |||
| £ million | balance | <1 year | 2 years | 5 years | > 5 years |
Bonds | (4,595) | (438) | (1,103) | (2,120) | (934) |
Cross-currency swaps | (5,501) | (1,715) | (1,099) | (1,581) | (1,106) |
(10,096) | (2,153) | (2,202) | (3,701) | (2,040) |
| 2023 | |||||
| Total | Maturity | ||||
| notional | Between 1 and | Between 2 and | |||
| balance | <1 year | 2 years | 5 years | > 5 years | |
Bonds | (3,897) | – | (433) | (2,645) | (819) |
Cross-currency swaps | (5,986) | (1,447) | (1,214) | (1,971) | (1,354) |
Foreign exchange swaps | (541) | (541) | – | – | – |
(10,424) | (1,988) | (1,647) | (4,616) | (2,173) |
| 2024 | |||||
| Carrying amount | Changes in fair | ||||
| value used for | |||||
| Notional | calculating hedge | ||||
| £ million | balance | Assets | Liabilities | Balance sheet line item | in-effectiveness |
| Hedging instrument: | |||||
Bonds | 4,595 | – | 4,584 | Borrowings | 321 |
Cross-currency swaps | 5,501 | 118 | 76 | Derivative financial instruments | 213 |
Foreign exchange swaps | – | – | – | Derivative financial instruments | 6 |
| Hedged item: | |||||
Investment in a foreign operation | n/a | 10,096 | – | 540 |
| 2023 | |||||
| Carrying amount | Changes in fair | ||||
| value used for | |||||
| calculating hedge | |||||
£ million | Notional balance | Assets | Liabilities | Balance sheet line item | in-effectiveness |
| Hedging instrument: | |||||
Bonds | 3,897 | – | 3,929 | Borrowings | 338 |
Cross-currency swaps | 5,986 | – | 249 | Derivative financial instruments | 75 |
Foreign exchange swaps | 541 | 1 | – | Derivative financial instruments | 14 |
| Hedged item: | |||||
Investment in a foreign operation | n/a | 10,424 | – | 427 |
| 2024 | |||||
| At the | Other | ||||
| beginning of | Income | comprehensive | Designations/(de- | At the end | |
| the year | statement | income | designations) | of the year | |
| Derivatives in net investment hedges of foreign | (248) | 71 | 219 | – | 42 |
| operations | |||||
Bonds in net investment hedges of foreign operations | (3,929) | 42 | 321 | (1,018) | (4,584) |
Total | (4,177) | 113 | 540 | (1,018) | (4,542) |
| 2023 | |||||
| At the | Other | ||||
| beginning of | Income | comprehensive | Designations/(de- | At the end | |
| £ million | the year | statement | income | designations) | of the year |
| Derivatives in net investment hedges of foreign | (338) | 1 | 89 | – | (248) |
| operations | |||||
Bonds in net investment hedges of foreign operations | (5,414) | (3) | 338 | 1,150 | (3,929) |
Total | (5,752) | (2) | 427 | 1,150 | (4,177) |
| 2024 | ||||
| Gross | Net financial | Related | ||
| financial | assets/ | amounts not | ||
| assets/ | (liabilities) per | set-off in the | ||
| £ million | (liabilities) | balance sheet | balance sheet | Net |
| Assets | ||||
Derivative financial instruments | 474 | 474 | (462) | 12 |
| Liabilities | ||||
Derivative financial instruments | (809) | (809) | 462 | (347) |
| 2023 | ||||
| Gross | Net financial | Related | ||
| financial | assets/ | amounts not | ||
| assets/ | (liabilities) per | set-off in the | ||
| £ million | (liabilities) | balance sheet | balance sheet | Net |
| Assets | ||||
Derivative financial instruments | 950 | 950 | (817) | 133 |
| Liabilities | ||||
Derivative financial instruments | (1,003) | (1,003) | 817 | (186) |
| 2024 | ||||||
| Fair value | Fair value | Assets and | ||||
| through | through other | liabilities at | ||||
| income | comprehensive | amortised | ||||
| £ million | statement | income | cost | Total | Current | Non-Current |
Trade and other receivables | – | – | 2,524 | 2,524 | 2,487 | 37 |
Cash and cash equivalents | – | – | 1,078 | 1,078 | 1,078 | – |
Derivatives | 356 | 118 | – | 474 | 144 | 330 |
Total financial assets | 356 | 118 | 3,602 | 4,076 | 3,709 | 367 |
Borrowings | – | – | (8,697) | (8,697) | (1,191) | (7,506) |
Trade and other payables | – | – | (8,659) | (8,659) | (8,659) | – |
Derivatives | (733) | (76) | – | (809) | (187) | (622) |
Lease liabilities | – | – | (386) | (386) | (86) | (300) |
Total financial liabilities | (733) | (76) | (17,742) | (18,551) | (10,123) | (8,428) |
Total net financial assets/(liabilities) | (377) | 42 | (14,140) | (14,475) | (6,414) | (8,061) |
| 2023 | ||||||
| Fair value | Fair value | Assets and | ||||
| through | through other | liabilities at | ||||
| income | comprehensive | amortised | ||||
| £ million | statement | income | cost | Total | Current | Non-current |
Trade and other receivables | – | – | 2,323 | 2,323 | 2,297 | 26 |
Cash and cash equivalents | – | – | 1,345 | 1,345 | 1,345 | – |
Derivatives | 949 | 1 | – | 950 | 126 | 824 |
Total financial assets | 949 | 1 | 3,668 | 4,618 | 3,768 | 850 |
Borrowings | – | – | (9,381) | (9,381) | (1,499) | (7,882) |
Trade and other payables | – | – | (8,705) | (8,705) | (8,705) | – |
Derivatives | (754) | (249) | – | (1,003) | (174) | (829) |
Lease liabilities | – | – | (349) | (349) | (81) | (268) |
Total financial liabilities | (754) | (249) | (18,435) | (19,438) | (10,459) | (8,979) |
Total net financial assets/(liabilities) | 195 | (248) | (14,767) | (14,820) | (6,691) | (8,129) |
2024 | 2023 | |||||
£ million | Assets | Liabilities | Net fair value | Assets | Liabilities | Net fair value |
| Current derivative financial instruments: | ||||||
Interest rate swaps | 65 | (54) | 11 | 30 | (66) | (36) |
Foreign exchange contracts | 1 | (4) | (3) | 12 | (5) | 7 |
Cross-currency swaps | 78 | (129) | (51) | 84 | (103) | (19) |
Total current derivatives | 144 | (187) | (43) | 126 | (174) | (48) |
| Non-current derivative financial instruments: | ||||||
Interest rate swaps | 240 | (365) | (125) | 745 | (652) | 93 |
Cross-currency swaps | 90 | (257) | (167) | 79 | (177) | (98) |
Total non-current derivatives | 330 | (622) | (292) | 824 | (829) | (5) |
| Total carrying value of derivative financial | ||||||
| instruments | 474 | (809) | (335) | 950 | (1,003) | (53) |
| Analysed as: | ||||||
Interest rate swaps | 305 | (419) | (114) | 775 | (718) | 57 |
Foreign exchange contracts | 1 | (4) | (3) | 12 | (5) | 7 |
Cross-currency swaps | 168 | (386) | (218) | 163 | (280) | (117) |
| Total carrying value of derivative financial | ||||||
| instruments | 474 | (809) | (335) | 950 | (1,003) | (53) |
| 2024 | |||||||
| Contractual | |||||||
| Balance sheet | cash flows | Between 1 and | Between 2 and | ||||
| £ million | amount | total | <1 year | 2 years | 5 years | >5 years | |
Net settled derivatives | (114) | 194 | 10 | 1 | 117 | 66 | |
Gross settled derivatives | (221) | – | – | – | – | – | |
| • | receipts | – | 20,719 | 6,490 | 2,730 | 5,762 | 5,737 |
| • | payments | – | (20,770) | (6,497) | (2,719) | (5,772) | (5,782) |
(335) | 143 | 3 | 12 | 107 | 21 |
| 2023 | |||||||
| Contractual | |||||||
| Balance sheet | cash flows | Between 1 and | Between 2 and | ||||
| £ million | amount | total | <1 year | 2 years | 5 years | >5 years | |
Net settled derivatives | 57 | 200 | (3) | 34 | 143 | 26 | |
Gross settled derivatives | (110) | – | – | – | – | – | |
| • | receipts | – | 17,822 | 5,429 | 4,010 | 5,283 | 3,100 |
| • | payments | – | (17,675) | (5,374) | (3,941) | (5,247) | (3,113) |
(53) | 347 | 52 | 103 | 179 | 13 |
£ million | 2024 | 2023 |
Foreign exchange gains on borrowings | 321 | 338 |
Foreign exchange gains on derivative financial instruments | 219 | 89 |
540 | 427 |
| Consolidated | Consolidated | Consolidated | Consolidated | |
| income | income | balance | balance | |
| statement | statement | sheet | sheet | |
| £ million | 2024 | 2023 | 2024 | 2023 |
Temporary differences on depreciation and amortisation | (53) | 164 | (711) | (716) |
Retirement benefits | (5) | (9) | 48 | 30 |
Tax credits and losses | 393 | 6 | 579 | 282 |
Accruals, provisions and other temporary differences | (48) | (3) | 193 | 186 |
Deferred tax benefit | 287 | 158 | ||
Net deferred tax assets/(liabilities) | 109 | (218) |
£ million | 2024 | 2023 |
Deferred tax assets | 889 | 653 |
Deferred tax liabilities | (780) | (871) |
109 | (218) |
£ million | 2024 | 2023 |
At 1 October | (218) | (522) |
Credited to the income statement | 287 | 158 |
Credited to other comprehensive income | 36 | 134 |
Credited to equity | 2 | 1 |
Acquisitions | – | (15) |
Exchange movements | 2 | 22 |
Other movements | (16) | 4 |
As at 30 September | 109 | (218) |
| Gross | Net | Gross | Net | |
| £ million | 2024 | 2024 | 2023 | 2023 |
Tax losses | 245 | 64 | 235 | 62 |
Tax credits | 806 | 282 | 15 | 15 |
Other temporary differences | 77 | 22 | 84 | 24 |
1,128 | 368 | 334 | 101 |
| Gross | Net | Gross | Net | |
| £ million | 2024 | 2024 | 2023 | 2023 |
| Tax losses expiring: | ||||
No expiry | 245 | 64 | 235 | 62 |
245 | 64 | 235 | 62 | |
| Tax credits expiring: | ||||
Within 1 year | – | – | 15 | 15 |
No expiry | 806 | 282 | – | – |
806 | 282 | 15 | 15 | |
| Other temporary differences expiring: | ||||
No expiry | 77 | 22 | 84 | 24 |
77 | 22 | 84 | 24 |
2024 | 2023 | |||||
DBO | Assets | Total | DBO | Assets | Total | |
At 1 October | (3,370) | 2,977 | (393) | (3,609) | 3,541 | (68) |
| Consolidated income statement expense: | ||||||
Current service cost | (18) | – | (18) | (25) | – | (25) |
Settlements gains/(losses) | 109 | (107) | 2 | 2 | (6) | (4) |
Past service income | 12 | – | 12 | 9 | – | 9 |
Cost of termination benefits | (2) | – | (2) | (5) | – | (5) |
| Net interest (expense)/income on net defined benefit | ||||||
| (liability)/asset | (171) | 160 | (11) | (165) | 178 | 13 |
Administration costs paid from plan assets | – | (5) | (5) | – | (5) | (5) |
Cost recognised in the income statement | (22) | (17) | ||||
| Remeasurements: | ||||||
Actuarial gain/(loss) due to liability experience | 13 | – | 13 | (132) | – | (132) |
| Actuarial (loss)/gain due to financial assumption | ||||||
| changes | (161) | – | (161) | 234 | – | 234 |
| Actuarial gain due to demographic assumption | ||||||
| changes | 1 | – | 1 | – | – | – |
| Return on plan assets excluding amounts included | ||||||
in net interest income/(expense) above Remeasurement effects recognised in other | – | 44 | 44 | – | (478) | (478) |
| comprehensive income | (103) | (376) | ||||
| Cash: | ||||||
Employer contributions | – | 55 | 55 | – | 59 | 59 |
Benefits paid directly by the Company | 247 | (247) | – | 265 | (265) | – |
Net cash | 55 | 59 | ||||
Changes to immaterial benefit plans categorised as an IAS 19 obligation recognised in the prior year | (11) | – | (11) | (8) | – | (8) |
Exchange movements | 64 | (33) | 31 | 64 | (47) | 17 |
Total other | 20 | 9 | ||||
At 30 September | (3,287) | 2,844 | (443) | (3,370) | 2,977 | (393) |
£ million | 2024 | 2023 |
Defined benefit expense in operating profit | 11 | 30 |
Defined contribution expense in operating profit | 23 | 16 |
Total retirement benefit scheme cost in operating profit | 34 | 46 |
£ million | 2024 | 2023 |
| Cost of sales | 12 | 15 |
Distribution, advertising and selling costs | 13 | 20 |
Administrative and other expenses | 9 | 11 |
Total retirement benefit scheme costs in operating profit | 34 | 46 |
£ million | 2024 | 2023 |
| Retirement benefit assets | 376 | 414 |
Retirement benefit liabilities | (819) | (807) |
Net retirement benefit liability | (443) | (393) |
2024 | 2023 | |||||
£ million unless otherwise indicated | ITPF | RCPP | ITG Scheme | ITPF | RCPP | ITG Scheme |
Defined benefit obligation (DBO) | 2,157 | 524 | 235 | 2,142 | 496 | 311 |
Fair value of scheme assets | (2,459) | – | (264) | (2,481) | – | (337) |
Net defined benefit (asset)/liability | (302) | 524 | (29) | (339) | 496 | (26) |
Current service cost | – | 7 | 2 | 6 | 8 | 2 |
Employer contributions | – | 23 | – | – | 23 | – |
| Principal actuarial assumptions used (% per annum) | ||||||
Discount rate | 5.1 | 3.4 | 4.8 | 5.6 | 4.2 | 5.7 |
Future salary increases | n/a | 3.1 | n/a | n/a | 3.5 | n/a |
Future pension increases | 3.2 | 2.0 | n/a | 3.4 | 2.4 | n/a |
Inflation | 3.1 | 2.0 | 2.3 | 3.4 | 2.4 | 2.3 |
| 2024 | ||||||
| ITPF | RCPP | ITG Scheme | ||||
Male | Female | Male | Female | Male | Female | |
| Life expectancy at age 65 years: | ||||||
Member currently aged 65 | 21.2 | 22.6 | 20.9 | 24.3 | 19.8 | 21.9 |
Member currently aged 50 | 22.0 | 23.9 | 22.9 | 25.9 | 21.0 | 23.0 |
| 2023 | ||||||
| ITPF | RCPP | ITG Scheme | ||||
Male | Female | Male | Female | Male | Female | |
| Life expectancy at age 65 years: | ||||||
Member currently aged 65 | 21.2 | 22.5 | 20.8 | 24.2 | 19.7 | 21.7 |
Member currently aged 50 | 21.9 | 23.8 | 22.8 | 25.8 | 20.8 | 22.8 |
2024 | 2023 | |||||
ITPF | RCPP | ITG Scheme | ITPF | RCPP | ITG Scheme | |
Discount rate: 0.5% decrease | 5.7 | 8.1 | 4.9 | 5.6 | 8.1 | 4.5 |
Rate of inflation: 0.5% decrease | (4.3) | (5.6) | n/a | (4.2) | (5.7) | n/a |
| One-year increase in longevity for a member currently age | ||||||
| 65, corresponding changes at other ages | 3.6 | 4.1 | 4.2 | 3.5 | 4.2 | 4.4 |
2024 | 2023 | |||
| Percentage of | Percentage of | |||
| ITPF scheme | ITPF scheme | |||
| £ million unless otherwise indicated | Fair value | assets | Fair value | assets |
Bonds - index linked government / LDI funds | 487 | 19.8 | 351 | 14.1 |
Property including ground leases | 446 | 18.1 | 488 | 19.7 |
Secured finance and private debt funds | 463 | 18.8 | 620 | 25.0 |
Insurance contract (buy-in policy) | 1,035 | 42.1 | 1,044 | 42.1 |
Other - including cash and short-term loan drawings | 28 | 1.1 | (22) | (0.9) |
2,459 | 100.0 | 2,481 | 100.0 |
2024 | 2023 | |||
P e r c e n t a g e o f | Percentage of | |||
I TG Schem e | ITG Scheme | |||
| £ million unless otherwise indicated | F a i i r v a l u e | a s s e t s | Fair value | assets |
Bonds - government, corporate and other | 122 | 46.2 | 203 | 60.2 |
Other - including derivatives, commodities and cash | 142 | 53.8 | 134 | 39.8 |
264 | 100.0 | 337 | 100.0 |
| 2024 | ||||
| Employment | ||||
| £ million | Restructuring | related claims | Other | Total |
At 1 October 2023 | 180 | 144 | 90 | 414 |
Additional provisions charged to the consolidated income statement | – | 14 | 34 | 48 |
Amounts used | (46) | (36) | (22) | (104) |
Unused amounts reversed | – | (3) | (30) | (33) |
Exchange movements | (4) | (7) | (3) | (14) |
At 30 September 2024 | 130 | 112 | 69 | 311 |
£ million | 2024 | 2023 |
Current | 89 | 148 |
Non-current | 222 | 266 |
311 | 414 |
2024 | 2023 | |||
Ordinary shares 10p each | Ordinary shares 10p each | |||
Number | £ million | Number | £ million | |
| Authorised, issued and fully paid: | ||||
1 October | 968,590,194 | 97 | 1,020,697,237 | 103 |
Shares cancelled | (54,087,312) | (6) | (52,107,043) | (6) |
30 September | 914,502,882 | 91 | 968,590,194 | 97 |
£ million | 2024 | 2023 |
Share Matching Scheme | 2 | 2 |
Long-Term Incentive Plan | 28 | 27 |
Sharesave Plan | 1 | 1 |
Discretionary Share Awards Plan | 1 | 1 |
32 | 31 |
| 2024 | |||||
| Sharesave | |||||
| Share | weighted | ||||
| Matching | average | ||||
| Scheme | LTIP | Sharesave | DSAP | exercise | |
| Thousands of shares unless otherwise indicated | awards | awards | options | awards | price £ |
Outstanding at 1 October 2023 | 453 | 8,502 | 1,686 | 173 | 13.72 |
Granted | 172 | 4,341 | 445 | 73 | 15.96 |
Cancelled/forfeited/lapsed | (20) | (1,608) | (138) | (11) | 13.61 |
Exercised | (234) | (2,670) | (453) | (24) | 13.10 |
Outstanding at 30 September 2024 | 371 | 8,565 | 1,540 | 211 | 14.78 |
Exercisable at 30 September 2024 | – | – | 42 | – | 13.09 |
| 2023 | |||||
| Share | Sharesave | ||||
| Matching | weighted | ||||
| average | |||||
| Scheme | LTIP | Sharesave | DSAP | exercise | |
| Thousands of shares unless otherwise indicated | awards | awards | options | awards | price £ |
Outstanding at 1 October 2022 | 486 | 8,120 | 1,934 | 120 | 13.21 |
Granted | 161 | 3,853 | 862 | 67 | 13.24 |
Cancelled/forfeited/lapsed | (18) | (2,402) | (90) | (11) | 12.63 |
Exercised | (176) | (1,069) | (1,020) | (3) | 12.38 |
Outstanding at 30 September 2023 | 453 | 8,502 | 1,686 | 173 | 13.72 |
Exercisable at 30 September 2023 | – | – | 264 | – | 12.37 |
| Vesting | |||
| Number of | period | Exercise price | |
| awards/options | remaining | of options | |
| Thousands of shares unless otherwise indicated | outstanding | in months | outstanding £ |
| Share Matching Scheme | |||
2022 | 128 | 5 | n/a |
2023 | 122 | 17 | n/a |
2024 | 121 | 29 | n/a |
Total awards outstanding | 371 | ||
| Long-Term Incentive Plan | |||
2022 | 2,313 | 5 | n/a |
2023 | 2,675 | 17 | n/a |
2024 | 3,577 | 29 | n/a |
Total awards outstanding | 8,565 | ||
| Sharesave Plan | |||
2021 | 42 | – | 13.09 |
2022 | 244 | 10 | 14.56 |
2023 | 815 | 22 | 14.29 |
2024 | 439 | 34 | 15.96 |
Total options outstanding | 1,540 | ||
| Discretionary Share Awards Plan | |||
2022 | 74 | 5 | n/a |
2023 | 65 | 18 | n/a |
2024 | 72 | 29 | n/a |
Total options outstanding | 211 |
| 2024 | |||
| Share | |||
| Matching | |||
| Scheme | Sharesave | DSAP | |
Risk-free interest rate % | 4.2 | 4.3 | 4.2 |
Volatility (based on 3-year history) % | 25.0 | 24.1 | 25.0 |
Expected lives of options granted years | 3.0 | 3.0 | 3.0 |
Dividend yield % | 7.6 | 7.6 | 7.6 |
Fair value £ | 14.56 | 3.40 | 14.55 |
Share price used to determine exercise price £ | 18.31 | 19.80 | 18.31 |
Exercise price £ | n/a | 15.96 | n/a |
| 2023 | |||
| Share | |||
| Matching | |||
| Scheme | Sharesave | DSAP | |
Risk-free interest rate % | 4.0 | 4.4 | 4.1 |
Volatility (based on 3-year history) % | 33.1 | 27.7 | 33.2 |
Expected lives of options granted years | 3.0 | 3.0 | 3.0 |
Dividend yield % | 8.2 | 8.2 | 8.2 |
Fair value £ | 16.04 | 3.30 | 14.72 |
Share price used to determine exercise price £ | 20.53 | 17.88 | 18.84 |
Exercise price £ | n/a | 14.29 | n/a |
% | 2024 | 2023 |
Future Imperial Brands share price volatility | 18.1 | 23.3 |
Future Imperial Brands dividend yield | – | – |
Share price volatility of the tobacco and alcohol comparator group | 15.4-23.1 | 15.9-63.5 |
Correlation between Imperial Tobacco and the alcohol and tobacco comparator group | 18.9 | 21.4 |
Millions of shares | 2024 | 2023 |
At 1 October | 1.6 | 3.7 |
Gift of shares from Treasury | 2.0 | – |
Distribution of shares held by Employee Share Ownership Trusts | (3.3) | (2.1) |
At 30 September | 0.3 | 1.6 |
2024 | 2023 | |||
| Millions of | Millions of | |||
| shares | Value | shares | Value | |
| £ million unless otherwise indicated | (number) | £ | (number) | £ |
At 1 October | 70.3 | 2,183 | 70.3 | 2,183 |
Gifted to Employee Share Ownership Trusts | (2.0) | – | – | – |
At 30 September | 68.3 | 2,183 | 70.3 | 2,183 |
Percentage of issued share capital | 7.5 | n/a | 7.3 | n/a |
£ million | 2024 | 2023 |
| Contracted but not provided for: | ||
Property, plant and equipment and software | 207 | 97 |
| Derivative | Liabilities | Cash | |||||
| Current | Lease | Non-current | financial | from financing | and cash | ||
| £ million | borrowings | liabilities | borrowings | instruments | activities | equivalents | Total |
At 1 October 2023 | (1,499) | (349) | (7,882) | (53) | (9,783) | 1,345 | (8,438) |
Reallocation of current borrowings from non- current borrowings | (1,673) | – | 1,673 | – | – | – | – |
Cash flow | 1,760 | 107 | (1,660) | 34 | 241 | (203) | 38 |
Change in accrued interest | 37 | (14) | (21) | 12 | 14 | – | 14 |
Change in fair values | – | – | – | (119) | (119) | – | (119) |
New leases, terminations and modifications | – | (144) | – | – | (144) | – | (144) |
Exchange movements | 184 | 14 | 384 | (209) | 373 | (64) | 309 |
At 30 September 2024 | (1,191) | (386) | (7,506) | (335) | (9,418) | 1,078 | (8,340) |
| Derivative | Liabilities | Cash | |||||
| Current | Lease | Non-current | financial | from financing | and cash | ||
| £ million | borrowings | liabilities | borrowings | instruments | activities | equivalents | Total |
At 1 October 2022 | (1,011) | (248) | (8,996) | (87) | (10,342) | 1,850 | (8,492) |
Reallocation of current borrowings from non- current borrowings | (1,536) | – | 1,536 | – | – | – | – |
Cash flow | 891 | 92 | (835) | 64 | 212 | (349) | (137) |
Change in accrued interest | 2 | (10) | (24) | 1 | (31) | – | (31) |
Change in fair values | – | – | – | 139 | 139 | – | 139 |
New leases, terminations and modifications | – | (106) | – | – | (106) | – | (106) |
Acquisitions | – | (84) | – | – | (84) | – | (84) |
Exchange movements | 155 | 7 | 437 | (170) | 429 | (156) | 273 |
At 30 September 2023 | (1,499) | (349) | (7,882) | (53) | (9,783) | 1,345 | (8,438) |
| 2024 | |||||
| £ million | GBP | EUR | USD | Other | Total |
Cash and cash equivalents | 356 | 179 | 129 | 414 | 1,078 |
Total borrowings | (1,014) | (3,383) | (4,291) | (9) | (8,697) |
(658) | (3,204) | (4,162) | 405 | (7,619) | |
Effect of cross-currency swaps | 1,022 | (5,532) | 4,292 | – | (218) |
364 | (8,736) | 130 | 405 | (7,837) | |
Lease liabilities | (39) | (265) | (47) | (35) | (386) |
Derivative financial instruments | (117) | ||||
Net debt | (8,340) |
| 2023 | |||||
| £ million | GBP | EUR | USD | Other | Total |
Cash and cash equivalents | 177 | 405 | 324 | 439 | 1,345 |
Total borrowings | (1,631) | (3,417) | (4,319) | (14) | (9,381) |
(1,454) | (3,012) | (3,995) | 425 | (8,036) | |
Effect of cross-currency swaps | 1,576 | (6,016) | 4,323 | – | (117) |
122 | (9,028) | 328 | 425 | (8,153) | |
Lease liabilities | (43) | (247) | (26) | (33) | (349) |
Derivative financial instruments | 64 | ||||
Net debt | (8,438) |
£ million | 2024 | 2023 |
Decrease in cash and cash equivalents | (203) | (349) |
Cash flows relating to derivative financial instruments | 34 | 64 |
Repayment of lease liabilities | 107 | 92 |
Increase in borrowings | (3,848) | (1,462) |
Repayment of borrowings | 3,948 | 1,518 |
Change in net debt resulting from cash flows | 38 | (137) |
Other non-cash movements including revaluation of derivative financial instruments | (105) | 108 |
Lease liabilities | (144) | (190) |
Exchange movements | 309 | 273 |
Movement in net debt during the year | 98 | 54 |
Opening net debt | (8,438) | (8,492) |
Closing net debt | (8,340) | (8,438) |
Euro million | 2024 | 2023 |
Current assets | 6,290 | 6,246 |
Current liabilities | (6,990) | (6,983) |
Current net liabilities | (700) | (737) |
Non-current assets | 1,790 | 1,816 |
Non-current liabilities | (449) | (482) |
Non-current net assets | 1,341 | 1,334 |
Net assets | 641 | 597 |
Euro million | 2024 | 2023 |
Revenue | 12,986 | 12,428 |
Profit for the year | 308 | 274 |
Other comprehensive income | – | 3 |
Total comprehensive income | 308 | 277 |
Euro million | 2024 | 2023 |
Cash flows from operating activities | 397 | 308 |
Cash flows from investing activities | (51) | (83) |
Cash flows from financing activities | (370) | (250) |
Net decrease in cash and cash equivalents | (24) | (25) |